Colin graduated with an honours degree in Pharmacology in 1988 and took up a research position at the University of Surrey investigating the action of novel muscarinic compounds. In 1990 he moved to the University of Keele to undertake a PhD studying the effect of imidazoline compounds on pancreatic beta cells. On completion of his PhD in 1993 he was appointed as a Post Doctoral Fellow in the Department of Cell Physiology and Pharmacology at the University of Leicester to take up a Wellcome Trust-funded Fellowship investigating the pharmacology of purinergic receptors in vascular endothelial cells.
Colin came to the University of Wolverhampton in 1997 to take up the post of Senior Lecturer in Pharmacology. In 2013 he was appointed to the post of Principal Lecturer and Head of Quality for the Faculty of Science and Engineering and in 2018 became Interim Head of the School of Pharmacy.
Cellular and Molecular Pharmacology.
The molecular pharmacology of P2Y purinergic receptors, and in particular, their role in the maintenance of vascular tone.
Research approaches include: